The Immunology and Safety of Maternal RSV Vaccination (ABRYSVO), Infant Nirsevimab (BEYFORTUS) Immunization, or Both Products
Clinical trial NCT06551506 · COMPLETED
Trial details
- NCT number
- NCT06551506
- Sponsor
- National Institute of Allergy and Infectious Diseases (NIAID)
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-19
- Primary completion
- 2026-05-05
- Enrollment
- 181
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.